Insider · CIK 0001827317

Nicholson Nur

Reports to the SEC for 2 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001827317

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-07	KLRAKailera Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Technology Officer	AAward	+220K sh	—	—	220,000
2026-05-14	APLSApellis Pharmaceuticals, Inc.U Disposition from Tender	Chief Technical Officer	UDisposition from Tender	−116K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.A Award	Chief Technical Officer	AAward	+22.6K sh	—	—	22,610
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	Chief Technical Officer	DDisposition to Issuer	−22.6K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.A Award	Chief Technical Officer	AAward	+45.2K sh	—	—	45,220
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	Chief Technical Officer	DDisposition to Issuer	−45.2K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.A Award	Chief Technical Officer	AAward	+24.3K sh	—	—	24,284
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	Chief Technical Officer	DDisposition to Issuer	−24.3K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.A Award	Chief Technical Officer	AAward	+41.3K sh	—	—	41,250
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	Chief Technical Officer	DDisposition to Issuer	−41.3K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	Chief Technical Officer	DDisposition to Issuer	−5,645 sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	Chief Technical Officer	DDisposition to Issuer	−9,754 sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	Chief Technical Officer	DDisposition to Issuer	−27.3K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc.D Disposition to Issuer	Chief Technical Officer	DDisposition to Issuer	−45.2K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Technical Officer	DDisposition to Issuer	−82.5K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Technical Officer	DDisposition to Issuer	−115K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Technical Officer	DDisposition to Issuer	−51K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Technical Officer	DDisposition to Issuer	−45K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Technical Officer	DDisposition to Issuer	−35.5K sh	—	—	0
2026-05-14	APLSApellis Pharmaceuticals, Inc. · Stock Option (right to buy)D Disposition to Issuer	Chief Technical Officer	DDisposition to Issuer	−28.4K sh	—	—	0
2026-01-28	APLSApellis Pharmaceuticals, Inc.A Award	Chief Technical Officer	AAward	+45.2K sh	—	—	116,338
2026-01-22	APLSApellis Pharmaceuticals, Inc.S Sale	Chief Technical Officer	SSale	−7,725 sh	$21.77	−$168K	71,118
2026-01-20	APLSApellis Pharmaceuticals, Inc.S Sale	Chief Technical Officer	SSale	−2,203 sh	$19.79	−$43.6K	78,843
2026-01-13	APLSApellis Pharmaceuticals, Inc.S Sale	Chief Technical Officer	SSale	−2,618 sh	$22.19	−$58.1K	81,046
2025-06-09	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Technical Officer	AAward	+82.5K sh	$19.39	+$1.6M	82,500
2025-01-29	APLSApellis Pharmaceuticals, Inc.S Sale	Chief Technical Officer	SSale	−825 sh	$29.52	−$24.4K	83,664
2025-01-22	APLSApellis Pharmaceuticals, Inc.S Sale	Chief Technical Officer	SSale	−3,948 sh	$30.43	−$120K	84,489
2025-01-21	APLSApellis Pharmaceuticals, Inc.A Award	Chief Technical Officer	AAward	+36.4K sh	—	—	88,437
2025-01-17	APLSApellis Pharmaceuticals, Inc.S Sale	Chief Technical Officer	SSale	−2,145 sh	$29.96	−$64.3K	52,011
2025-01-13	APLSApellis Pharmaceuticals, Inc.S Sale	Chief Technical Officer	SSale	−2,632 sh	$28.70	−$75.5K	54,156
2024-03-13	APLSApellis Pharmaceuticals, Inc.S Sale	Chief Technical Officer	SSale	−7,768 sh	$57.31	−$445K	59,739
2024-03-13	APLSApellis Pharmaceuticals, Inc.S Sale	Chief Technical Officer	SSale	−3,452 sh	$58.13	−$201K	56,287
2024-01-29	APLSApellis Pharmaceuticals, Inc.S Sale	Chief Technical Officer	SSale	−835 sh	$64.14	−$53.6K	67,507
2024-01-22	APLSApellis Pharmaceuticals, Inc.S Sale	Chief Technical Officer	SSale	−2,593 sh	$65.00	−$169K	68,342
2024-01-16	APLSApellis Pharmaceuticals, Inc.A Award	Chief Technical Officer	AAward	+19.5K sh	—	—	72,792
2024-01-16	APLSApellis Pharmaceuticals, Inc.S Sale	Chief Technical Officer	SSale	−1,857 sh	$66.81	−$124K	70,935
2024-01-16	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Technical Officer	AAward	+28.4K sh	$66.30	+$1.88M	28,367
2023-09-18	APLSApellis Pharmaceuticals, Inc.M Exercise/Conversion	Chief Technical Officer	MExercise/Conversion	+9,719 sh	$29.76	+$289K	73,634
2023-09-18	APLSApellis Pharmaceuticals, Inc.S Sale	Chief Technical Officer	SSale	−9,719 sh	$42.21	−$410K	63,915
2023-09-18	APLSApellis Pharmaceuticals, Inc.S Sale	Chief Technical Officer	SSale	−10.6K sh	$46.15	−$491K	53,284
2023-09-18	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Technical Officer	MExercise/Conversion	−9,719 sh	—	—	115,281
2023-02-21	APLSApellis Pharmaceuticals, Inc.A Award	Chief Technical Officer	AAward	+9,886 sh	—	—	64,328
2023-02-21	APLSApellis Pharmaceuticals, Inc.F Tax Payment	Chief Technical Officer	FTax Payment	−825 sh	$58.50	−$48.3K	63,503
2023-02-21	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Technical Officer	AAward	+14K sh	—	—	14,023
2023-01-27	APLSApellis Pharmaceuticals, Inc.F Tax Payment	Chief Technical Officer	FTax Payment	−551 sh	$52.77	−$29.1K	54,442
2023-01-20	APLSApellis Pharmaceuticals, Inc.F Tax Payment	Chief Technical Officer	FTax Payment	−2,034 sh	$52.05	−$106K	54,993
2023-01-12	APLSApellis Pharmaceuticals, Inc.A Award	Chief Technical Officer	AAward	+22.6K sh	—	—	57,027
2023-01-12	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Technical Officer	AAward	+35.5K sh	$52.66	+$1.87M	35,472
2022-04-25	APLSApellis Pharmaceuticals, Inc.J Other	Chief Technical Officer	JOther	−1,875 sh	—	—	33,680
2022-04-25	APLSApellis Pharmaceuticals, Inc. · Stock Option (Right to Buy)J Other	Chief Technical Officer	JOther	−11.3K sh	—	—	0

Recent filings

Accepted (ET)
Sep 94
Nicholson Nur0001193125-26-386782
SEC(opens sec.gov)
May 144
Nicholson Nur0001193125-26-224604
SEC(opens sec.gov)

Companies

Address

C/O KAILERA THERAPEUTICS, INC. 180 THIRD AVENUE, 4TH FLOOR

WALTHAM, MA, 02451